{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:26:00Z","timestamp":1768699560223,"version":"3.49.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81728012"],"award-info":[{"award-number":["81728012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LY18H160065"],"award-info":[{"award-number":["LY18H160065"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00432-018-2727-0","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T21:58:49Z","timestamp":1533247129000},"page":"2097-2106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The hippo pathway provides novel insights into lung cancer and mesothelioma treatment"],"prefix":"10.1007","volume":"144","author":[{"given":"Xiao-Lan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-9442","authenticated-orcid":false,"given":"Wen-Bin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"2727_CR1","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/sj.onc.1204175","volume":"20","author":"A Agathanggelou","year":"2001","unstructured":"Agathanggelou A, Honorio S, Macartney D et al (2001) Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20:1509\u20131518. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1204175","journal-title":"Oncogene"},{"key":"2727_CR2","doi-asserted-by":"publisher","first-page":"e0127841","DOI":"10.1371\/journal.pone.0127841","volume":"10","author":"MB Aldonza","year":"2015","unstructured":"Aldonza MB, Hong JY, Bae SY et al (2015) Suppression of MAPK signaling and reversal of mTOR-dependent MDR1-associated multidrug resistance by 21alpha-methylmelianodiol in lung cancer cells. PLoS One 10:e0127841. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0127841","journal-title":"PLoS One"},{"key":"2727_CR3","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.1158\/0008-5472.can-05-2312","volume":"65","author":"DA Altomare","year":"2005","unstructured":"Altomare DA (2005) A mouse model recapitulating molecular features of human mesothelioma. Cancer Res 65:8090\u20138095. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-05-2312","journal-title":"Cancer Res"},{"key":"2727_CR4","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","volume":"92","author":"A Bianchi","year":"1995","unstructured":"Bianchi A, Mitsunaga S, Cheng J et al (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA 92:10854\u201310858","journal-title":"Proc Natl Acad Sci USA"},{"key":"2727_CR5","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/stem.1993","volume":"33","author":"N Bora-Singhal","year":"2015","unstructured":"Bora-Singhal N, Nguyen J, Schaal C et al (2015) YAP1 regulates OCT4 Activity and SOX2 expression to facilitate self-renewal and vascular mimicry of stem-like cells. Stem Cells 33:1705\u20131718. \n                    https:\/\/doi.org\/10.1002\/stem.1993","journal-title":"Stem Cells"},{"key":"2727_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaa9227","author":"D Bui","year":"2016","unstructured":"Bui D, Lee W, White A et al (2016) Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. Sci Signal. \n                    https:\/\/doi.org\/10.1126\/scisignal.aaa9227","journal-title":"Sci Signal"},{"key":"2727_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ly BH, Dodson RF et al (2012) Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 227:44\u201358. \n                    https:\/\/doi.org\/10.1002\/jcp.22724","journal-title":"J Cell Physiol"},{"key":"2727_CR8","doi-asserted-by":"publisher","first-page":"e2637","DOI":"10.1371\/journal.pone.0002637","volume":"3","author":"Y-C Chen","year":"2008","unstructured":"Chen Y-C, Hsu H-S, Chen Y-W et al (2008) Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3:e2637. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0002637","journal-title":"PLoS One"},{"key":"2727_CR9","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1200\/JCO.2014.59.3590","volume":"33","author":"HY Chen","year":"2015","unstructured":"Chen HY, Yu SL, Ho BC et al (2015) R331W missense mutation of oncogene YAP1 Is a Germline risk allele for lung adenocarcinoma with medical actionability. J Clinical Oncol 33:2303\u20132310. \n                    https:\/\/doi.org\/10.1200\/JCO.2014.59.3590","journal-title":"J Clinical Oncol"},{"key":"2727_CR10","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1200\/JCO.2014.59.3590","volume":"54","author":"JQ Cheng","year":"1994","unstructured":"Cheng JQ, Jhanwar SC, Klein WM et al (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54:5547. \n                    https:\/\/doi.org\/10.1200\/JCO.2014.59.3590","journal-title":"Cancer Res"},{"key":"2727_CR11","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.21037\/jtd.2017.07.18","volume":"9","author":"Y Dai","year":"2017","unstructured":"Dai Y, Jablons D, You L (2017a) Hippo pathway in lung development. J Thorac Dis 9:2246\u20132250. \n                    https:\/\/doi.org\/10.21037\/jtd.2017.07.18","journal-title":"J Thorac Dis"},{"key":"2727_CR12","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.18632\/oncotarget.13686","volume":"8","author":"Y Dai","year":"2017","unstructured":"Dai Y, Liu S, Zhang W-Q et al (2017b) YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells. Oncotarget 8:4096\u20134109. \n                    https:\/\/doi.org\/10.18632\/oncotarget.13686","journal-title":"Oncotarget"},{"key":"2727_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cub.2010","volume":"20","author":"M Das Thakur","year":"2010","unstructured":"Das Thakur M, Feng Y, Jagannathan R et al (2010) Ajuba LIM proteins are negative regulators of the hippo signaling pathway. Curr Biol 20:657\u2013662. \n                    https:\/\/doi.org\/10.1016\/j.cub.2010\n                    \n                  . 02.035","journal-title":"Curr Biol"},{"key":"2727_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2174\/1389450117666160112110204","volume":"17","author":"C David","year":"2016","unstructured":"David C, Marina Villanueva P, Elizabet A-G et al (2016) AMPK as a target in rare diseases. Curr Drug Targets 17:921\u2013931. \n                    https:\/\/doi.org\/10.2174\/1389450117666160112110204","journal-title":"Curr Drug Targets"},{"key":"2727_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.celrep.2014.09.036","volume":"9","author":"M DeRan","year":"2014","unstructured":"DeRan M, Yang J, Shen C-H et al (2014) Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep 9:495\u2013503. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2014.09.036","journal-title":"Cell Rep"},{"key":"2727_CR16","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1242\/jcs.010389","volume":"120","author":"H Donninger","year":"2007","unstructured":"Donninger H, Vos MD, Clark GJ (2007) The RASSF1A tumor suppressor. J Cell Sci 120:3163\u20133172. \n                    https:\/\/doi.org\/10.1242\/jcs.010389","journal-title":"J Cell Sci"},{"key":"2727_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1128\/mcb.00202-14","volume":"35","author":"H Donninger","year":"2015","unstructured":"Donninger H, Clark J, Rinaldo F et al (2015) The RASSF1A tumor suppressor regulates XPA-mediated DNA repair. Mol Cell Biol 35:277\u2013287. \n                    https:\/\/doi.org\/10.1128\/mcb.00202-14","journal-title":"Mol Cell Biol"},{"key":"2727_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/abbs\/gmu112","volume":"47","author":"X Du","year":"2014","unstructured":"Du X, Yu A, Tao W (2014) The non-canonical Hippo\/Mst pathway in lymphocyte development and functions. Acta Biochim Biophys Sin 47:60\u201364. \n                    https:\/\/doi.org\/10.1093\/abbs\/gmu112","journal-title":"Acta Biochim Biophys Sin"},{"key":"2727_CR19","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1158\/0008-5472.CAN-15-1008","volume":"76","author":"F Dubois","year":"2016","unstructured":"Dubois F, Keller M, Calvayrac O et al (2016) RASSF1A suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting YAP activation through the GEF-H1\/RhoB pathway. Cancer Res 76:1627\u20131640. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1008","journal-title":"Cancer Res"},{"key":"2727_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","volume":"15","author":"A Eramo","year":"2007","unstructured":"Eramo A, Lotti F, Sette G et al (2007) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504\u2013514. \n                    https:\/\/doi.org\/10.1038\/sj.cdd.4402283","journal-title":"Cell Death Differ"},{"key":"2727_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20111653","volume":"209","author":"M Fujii","year":"2012","unstructured":"Fujii M, Toyoda T, Nakanishi H et al (2012) TGF-\u03b2 synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med 209:479\u2013494.\n                    https:\/\/doi.org\/10.1084\/jem.20111653","journal-title":"J Exp Med"},{"key":"2727_CR22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2014.06.029","volume":"158","author":"J Ganem Neil","year":"2014","unstructured":"Ganem Neil J, Cornils H, Chiu S-Y et al (2014) Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell 158:833\u2013848. \n                    https:\/\/doi.org\/10.1016\/j.cell.2014.06.029","journal-title":"Cell"},{"key":"2727_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1586\/14737140.2016.1162103","volume":"16","author":"X Gao","year":"2016","unstructured":"Gao X, Le X, Costa DB (2016) The safety and efficacy of osimertinib for the treatment of EGFR T790M mutation positive non-small-cell lung cancer. Expert Rev Anticancer Ther 16:383\u2013390. \n                    https:\/\/doi.org\/10.1586\/14737140.2016.1162103","journal-title":"Expert Rev Anticancer Ther"},{"key":"2727_CR24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMe0905763","volume":"361","author":"AF Gazdar","year":"2009","unstructured":"Gazdar AF (2009) Personalized medicine and inhibition of EGFR signaling in lung cancer. N Engl J Med 361:1018\u20131020. \n                    https:\/\/doi.org\/10.1056\/NEJMe0905763","journal-title":"N Engl J Med"},{"key":"2727_CR25","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-11-1780","volume":"72","author":"SV Holt","year":"2012","unstructured":"Holt SV, Logie A, Davies BR et al (2012) Enhanced apoptosis and tumor growth suppression elicited by combination of MEK (selumetinib) and mTOR kinase inhibitors (AZD8055). Cancer Res 72:1804\u20131813. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1780","journal-title":"Cancer Res"},{"key":"2727_CR26","doi-asserted-by":"publisher","first-page":"51922","DOI":"10.18632\/oncotarget.10458","volume":"7","author":"P-C Hsu","year":"2016","unstructured":"Hsu P-C, You B, Yang Y-L et al (2016) YAP promotes erlotinib resistance in human non-small cell lung cancer cells. Oncotarget 7:51922\u201351933. \n                    https:\/\/doi.org\/10.18632\/oncotarget.10458","journal-title":"Oncotarget"},{"key":"2727_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2012.08.021","volume":"328","author":"C-P Huang","year":"2013","unstructured":"Huang C-P, Tsai M-F, Chang T-H et al (2013) ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett 328:144\u2013151. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2012.08.021","journal-title":"Cancer Lett"},{"key":"2727_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/LCTT.S16310","volume":"2","author":"JL Hurwitz","year":"2011","unstructured":"Hurwitz JL, Scullin P, Campbell L (2011) Afatinib treatment in advanced non-small cell lung cancer. Lung Cancer 2:47\u201357. \n                    https:\/\/doi.org\/10.2147\/LCTT.S16310","journal-title":"Lung Cancer"},{"key":"2727_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106\u2013130. \n                    https:\/\/doi.org\/10.3322\/canjclin.56.2.106","journal-title":"CA Cancer J Clin"},{"key":"2727_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/path.4075","volume":"228","author":"L Jiang","year":"2012","unstructured":"Jiang L, Akatsuka S, Nagai H et al (2012) Iron overload signature in chrysotile-induced malignant mesothelioma. J Pathol 228:366\u2013377. \n                    https:\/\/doi.org\/10.1002\/path.4075","journal-title":"J Pathol"},{"key":"2727_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2015.11.011","volume":"468","author":"A Jin","year":"2015","unstructured":"Jin A, Neufeld TP, Choe J (2015) Kibra and aPKC regulate starvation-induced autophagy in Drosophila. Biochem Biophys Res Commun 468:1\u20137. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2015.11.011","journal-title":"Biochem Biophys Res Commun"},{"key":"2727_CR32","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.cub2015.08.031","volume":"25","author":"C Joffre","year":"2015","unstructured":"Joffre C, Dupont N, Hoa L et al (2015) The pro-apoptotic STK38 kinase is a new Beclin1 partner positively regulating autophagy. Curr Biol 25:2479\u20132492. \n                    https:\/\/doi.org\/10.1016\/j.cub2015.08.031","journal-title":"Curr Biol"},{"key":"2727_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgw084","author":"T Kakiuchi","year":"2016","unstructured":"Kakiuchi T, Takahara T, Kasugai Y et al (2016) Modeling mesothelioma utilizing human mesothelial cells reveals involvement of phospholipase-C beta 4 in YAP-active mesothelioma cell proliferation. Carcinogenesis. \n                    https:\/\/doi.org\/10.1093\/carcin\/bgw084","journal-title":"Carcinogenesis"},{"key":"2727_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/emboj.2009.82","volume":"28","author":"K Katagiri","year":"2009","unstructured":"Katagiri K, Katakai T, Ebisuno Y et al (2009) Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J 28:1319\u20131331. \n                    https:\/\/doi.org\/10.1038\/emboj.2009.82","journal-title":"EMBO J"},{"key":"2727_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.humpath.2010.08.003","volume":"42","author":"JM Kim","year":"2011","unstructured":"Kim JM, Kang DW, Long LZ et al (2011) Differential expression of Yes-associated protein is correlated with expression of cell cycle markers and pathologic TNM staging in non small-cell lung carcinoma. Hum Pathol 42:315\u2013323. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2010.08.003","journal-title":"Hum Pathol"},{"key":"2727_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3978\/j.issn2218-6751.2014.11.11","volume":"4","author":"T Kohno","year":"2015","unstructured":"Kohno T, Nakaoku T, Tsuta K et al (2015) Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer. Transl Lung Cancer Res 4:156\u2013164. \n                    https:\/\/doi.org\/10.3978\/j.issn2218-6751.2014.11.11","journal-title":"Transl Lung Cancer Res"},{"key":"2727_CR37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/embj201386082","volume":"33","author":"AN Lau","year":"2014","unstructured":"Lau AN, Curtis SJ, Fillmore CM et al (2014) Tumor-propagating cells and Yap\/Taz activity contribute to lung tumor progression and metastasis. EMBO J 33:468\u2013481. \n                    https:\/\/doi.org\/10.1002\/embj201386082","journal-title":"EMBO J"},{"key":"2727_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2016.04.089","volume":"474","author":"JE Lee","year":"2016","unstructured":"Lee JE, Park HS, Lee D et al (2016) Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance. Biochem Biophys Res Commun 474:154\u2013160. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2016.04.089","journal-title":"Biochem Biophys Res Commun"},{"key":"2727_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.molcel.2007.12.022","volume":"29","author":"D Levy","year":"2008","unstructured":"Levy D, Adamovich Y, Reuven N et al (2008) Yap1 phosphorylation by c-Abl Is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 29:350\u2013361. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2007.12.022","journal-title":"Mol Cell"},{"key":"2727_CR40","doi-asserted-by":"publisher","first-page":"e113574","DOI":"10.1371\/journal.pone.0113574","volume":"9","author":"D Li","year":"2014","unstructured":"Li D, Wei L, Xu B et al (2014) Association of GWAS-identified lung cancer susceptibility loci with survival length in patients with small-cell lung cancer treated with platinum-based chemotherapy. PLoS One 9:e113574. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0113574","journal-title":"PLoS One"},{"key":"2727_CR41","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.20140341","volume":"211","author":"N Liang","year":"2014","unstructured":"Liang N, Zhang C, Dill P et al (2014) Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med 211:2249\u20132263. \n                    https:\/\/doi.org\/10.1084\/jem.20140341","journal-title":"J Exp Med"},{"key":"2727_CR42","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1007\/s13277-014-1826-z","volume":"35","author":"XY Lin","year":"2014","unstructured":"Lin XY, Zhang XP, Wu JH et al (2014) Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer. Tumour Biol 35:6435\u20136443. \n                    https:\/\/doi.org\/10.1007\/s13277-014-1826-z","journal-title":"Tumour Biol"},{"key":"2727_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40169-017-0136-7","volume":"6","author":"X Liu","year":"2017","unstructured":"Liu X, Cho WC (2017) Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer. Clin Transl Med 6:7. \n                    https:\/\/doi.org\/10.1186\/s40169-017-0136-7","journal-title":"Clin Transl Med"},{"key":"2727_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.lungcan.2014.05.025","volume":"85","author":"SY Luo","year":"2014","unstructured":"Luo SY, Sit K-Y, Sihoe A et al (2014) Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas. Lung Cancer 85:282\u2013292. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2014.05.025","journal-title":"Lung Cancer"},{"key":"2727_CR45","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/nm.3322","volume":"19","author":"Y Maejima","year":"2013","unstructured":"Maejima Y, Kyoi S, Zhai P et al (2013) Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med 19:1478\u20131488. \n                    https:\/\/doi.org\/10.1038\/nm.3322","journal-title":"Nat Med"},{"key":"2727_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.devcel.2014.06.003","volume":"30","author":"J Mahoney","year":"2014","unstructured":"Mahoney J, Mori M, Szymaniak A et al (2014) The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors. Dev Cell 30:137\u2013150. \n                    https:\/\/doi.org\/10.1016\/j.devcel.2014.06.003","journal-title":"Dev Cell"},{"key":"2727_CR47","doi-asserted-by":"publisher","first-page":"F542","DOI":"10.1152\/ajprenal.00201.2007","volume":"294","author":"R Makita","year":"2008","unstructured":"Makita R, Uchijima Y, Nishiyama K et al (2008) Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am J Physiol Renal Physiol 294:F542\u2013F553. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00201.2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2727_CR48","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.molonc.2016.06.005","volume":"10","author":"M Meerang","year":"2016","unstructured":"Meerang M, Berard K, Friess M et al (2016) Low merlin expression and high survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma. Mol Oncol 10:1255\u20131265. \n                    https:\/\/doi.org\/10.1016\/j.molonc.2016.06.005","journal-title":"Mol Oncol"},{"key":"2727_CR49","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/jto.0000000000000493","volume":"10","author":"A Miyanaga","year":"2015","unstructured":"Miyanaga A, Masuda M, Tsuta K et al (2015) Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol 10:844\u2013851. \n                    https:\/\/doi.org\/10.1097\/jto.0000000000000493","journal-title":"J Thorac Oncol"},{"key":"2727_CR50","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1038\/onc.2012.5","volume":"31","author":"T Mizuno","year":"2012","unstructured":"Mizuno T, Murakami H, Fujii M et al (2012) YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes. Oncogene 31:5117\u20135122. \n                    https:\/\/doi.org\/10.1038\/onc.2012.5","journal-title":"Oncogene"},{"key":"2727_CR51","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ncb3111","volume":"17","author":"J-S Mo","year":"2015","unstructured":"Mo J-S, Meng Z, Kim YC et al (2015) Cellular energy stress induces AMPK-mediated regulation of YAP and the hippo pathway. Nat Cell Biol 17:500\u2013510. \n                    https:\/\/doi.org\/10.1038\/ncb3111","journal-title":"Nat Cell Biol"},{"key":"2727_CR52","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cell.2016.11.005","volume":"167","author":"T Moroishi","year":"2016","unstructured":"Moroishi T, Hayashi T, Pan W-W et al (2016) The hippo pathway kinases LATS1\/2 suppress cancer immunity. Cell 167:1525\u20131539.e1517. \n                    https:\/\/doi.org\/10.1016\/j.cell.2016.11.005","journal-title":"Cell"},{"key":"2727_CR53","doi-asserted-by":"publisher","first-page":"16173","DOI":"10.1038\/srep16173","volume":"5","author":"S Mukai","year":"2015","unstructured":"Mukai S, Yabuta N, Yoshida K et al (2015) Lats1 suppresses centrosome overduplication by modulating the stability of Cdc25B. Sci Rep 5:16173. \n                    https:\/\/doi.org\/10.1038\/srep16173","journal-title":"Sci Rep"},{"key":"2727_CR54","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/0008-5472.can-10-2164","volume":"71","author":"H Murakami","year":"2011","unstructured":"Murakami H, Mizuno T, Taniguchi T et al (2011) LATS2 Is a tumor suppressor gene of malignant mesothelioma. Cancer Res 71:873\u2013883. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-10-2164","journal-title":"Cancer Res"},{"key":"2727_CR55","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/emboj.2011.1","volume":"30","author":"F Napoletano","year":"2011","unstructured":"Napoletano F, Occhi S, Calamita P et al (2011) Polyglutamine atrophin provokes neurodegeneration in Drosophila by repressing fat. EMBO J 30:945\u2013958. \n                    https:\/\/doi.org\/10.1038\/emboj.2011.1","journal-title":"EMBO J"},{"key":"2727_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0092-8674(00)81769-9","volume":"95","author":"J Nichols","year":"1998","unstructured":"Nichols J, Zevnik B, Anastassiadis K et al (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379\u2013391. \n                    https:\/\/doi.org\/10.1016\/S0092-8674(00)81769-9","journal-title":"Cell"},{"key":"2727_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005199","author":"A Nishikimi","year":"2014","unstructured":"Nishikimi A, Ishihara S, Ozawa M et al (2014) Rab13 acts downstream of the kinase Mst1 to to deliver the integrin LFA-1 to the cell surface for lymphocyte trafficking. Sci Signal. \n                    https:\/\/doi.org\/10.1126\/scisignal.2005199","journal-title":"Sci Signal"},{"key":"2727_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.75","author":"A Noto","year":"2017","unstructured":"Noto A, De Vitis C, Pisanu ME et al (2017) Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP\/TAZ. Oncogene. \n                    https:\/\/doi.org\/10.1038\/onc.2017.75","journal-title":"Oncogene"},{"key":"2727_CR59","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497\u20131500. \n                    https:\/\/doi.org\/10.1126\/science.1099314","journal-title":"Science"},{"key":"2727_CR60","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao W, Miller V, Zakowski M et al (2004) EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101:13306\u201313311. \n                    https:\/\/doi.org\/10.1073\/pnas.0405220101","journal-title":"Proc Natl Acad Sci USA"},{"key":"2727_CR61","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.cub.2012.06.075","volume":"22","author":"CL Poon","year":"2012","unstructured":"Poon CL, Zhang X, Lin JI et al (2012) Homeodomain-interacting protein kinase regulates Hippo pathway-dependent tissue growth. Curr Biol 22:1587\u20131594. \n                    https:\/\/doi.org\/10.1016\/j.cub.2012.06.075","journal-title":"Curr Biol"},{"key":"2727_CR62","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/cdd.2013.83","volume":"20","author":"N Reuven","year":"2013","unstructured":"Reuven N, Adler J, Meltser V et al (2013) The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl. Cell Death Differ 20:1330\u20131340. \n                    https:\/\/doi.org\/10.1038\/cdd.2013.83","journal-title":"Cell Death Differ"},{"key":"2727_CR63","doi-asserted-by":"publisher","first-page":"16478","DOI":"10.1074\/jbc.M114.628982","volume":"290","author":"N Reuven","year":"2015","unstructured":"Reuven N, Adler J, Porat Z et al (2015) The Tyrosine kinase c-Abl promotes homeodomain-interacting protein kinase 2 (HIPK2) accumulation and activation in response to DNA damage. J Biol Chem 290:16478\u201316488. \n                    https:\/\/doi.org\/10.1074\/jbc.M114.628982","journal-title":"J Biol Chem"},{"key":"2727_CR64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1158\/0008-5472.CAN-13-1103","volume":"74","author":"JK Rho","year":"2014","unstructured":"Rho JK, Choi YJ, Kim SY et al (2014) MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation. Cancer Res 74:253. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1103","journal-title":"Cancer Res"},{"key":"2727_CR65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cllc.2013.04.006","volume":"14","author":"SI Rothschild","year":"2013","unstructured":"Rothschild SI, Gautschi O (2013) Crizotinib in the treatment of non-small-cell lung cancer. Clin Lung Cancer 14:473\u2013480. \n                    https:\/\/doi.org\/10.1016\/j.cllc.2013.04.006","journal-title":"Clin Lung Cancer"},{"key":"2727_CR66","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1586\/17476348.2015.1009040","volume":"9","author":"M Santarpia","year":"2015","unstructured":"Santarpia M, Altavilla G, Rosell R (2015) Alectinib: a selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer. Expert Rev Respir Med 9:255\u2013268. \n                    https:\/\/doi.org\/10.1586\/17476348.2015.1009040","journal-title":"Expert Rev Respir Med"},{"key":"2727_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.2009.01336.x","volume":"101","author":"Y Sekido","year":"2010","unstructured":"Sekido Y (2010) Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. Cancer Sci 101:1\u20136. \n                    https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01336.x","journal-title":"Cancer Sci"},{"key":"2727_CR68","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1126\/science.1224922","volume":"337","author":"L Senovilla","year":"2012","unstructured":"Senovilla L, Vitale I, Martins I et al (2012) An immunosurveillance mechanism controls cancer cell ploidy. Science 337:1678\u20131684. \n                    https:\/\/doi.org\/10.1126\/science.1224922","journal-title":"Science"},{"key":"2727_CR69","doi-asserted-by":"publisher","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","volume":"3","author":"LV Sequist","year":"2011","unstructured":"Sequist LV, Waltman BA, Dias-Santagata D et al (2011) Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 3:75ra26. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.3002003","journal-title":"Sci Transl Med"},{"key":"2727_CR70","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1158\/0008-5472.CAN-12-4136","volume":"73","author":"K Shien","year":"2013","unstructured":"Shien K, Toyooka S, Yamamoto H et al (2013) Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell\u2013like properties in cancer cells. Cancer Res 73:3051\u20133061. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4136","journal-title":"Cancer Res"},{"key":"2727_CR71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.21496","volume":"118","author":"H Shigematsu","year":"2006","unstructured":"Shigematsu H, Gazdar AF (2006) Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 118:257\u2013262. \n                    https:\/\/doi.org\/10.1002\/ijc.21496","journal-title":"Int J Cancer"},{"key":"2727_CR72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1476-4598-11-73","volume":"11","author":"S Singh","year":"2012","unstructured":"Singh S, Trevino J, Bora-Singhal N et al (2012) EGFR\/Src\/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer 11:73. \n                    https:\/\/doi.org\/10.1186\/1476-4598-11-73","journal-title":"Mol Cancer"},{"key":"2727_CR73","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/1471-2407-12-558","volume":"12","author":"H Tanaka","year":"2012","unstructured":"Tanaka H, Hayashi A, Morimoto T et al (2012) A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene. BMC Cancer 12:558. \n                    https:\/\/doi.org\/10.1186\/1471-2407-12-558","journal-title":"BMC Cancer"},{"key":"2727_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/onc.2013.528","volume":"34","author":"I Tanaka","year":"2015","unstructured":"Tanaka I, Osada H, Fujii M et al (2015) LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade. Oncogene 34:73\u201383. \n                    https:\/\/doi.org\/10.1038\/onc.2013.528","journal-title":"Oncogene"},{"key":"2727_CR75","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2016.10.020","volume":"385","author":"K Tanaka","year":"2017","unstructured":"Tanaka K, Osada H, Murakami-Tonami Y et al (2017) Statin suppresses hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP\/CD44 growth stimulatory axis. Cancer Lett 385:215\u2013224. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2016.10.020","journal-title":"Cancer Lett"},{"key":"2727_CR76","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.3892\/or.2014.3470","volume":"32","author":"Y Tang","year":"2014","unstructured":"Tang Y, Hou J, Li G et al (2014) ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines. Oncol Rep 32:2168\u20132174. \n                    https:\/\/doi.org\/10.3892\/or.2014.3470","journal-title":"Oncol Rep"},{"key":"2727_CR77","doi-asserted-by":"publisher","first-page":"ra100","DOI":"10.1126\/scisignal.aab2425","volume":"8","author":"F Tang","year":"2015","unstructured":"Tang F, Gill J, Ficht X et al (2015) The kinases NDR1_2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motility. Sci Signal 8:ra100. \n                    https:\/\/doi.org\/10.1126\/scisignal.aab2425","journal-title":"Sci Signal"},{"key":"2727_CR78","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1349-7006.2006.00386.x","volume":"98","author":"T Taniguchi","year":"2007","unstructured":"Taniguchi T, Karnan S, Fukui T et al (2007) Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32. Cancer Sci 98: 438\u2013446. \n                    https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00386.x","journal-title":"Cancer Sci"},{"key":"2727_CR79","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J et al (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022\u20131025. \n                    https:\/\/doi.org\/10.1038\/ng.912","journal-title":"Nat Genet"},{"key":"2727_CR80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.lungcan.2010.11.014","volume":"71","author":"M Tiseo","year":"2011","unstructured":"Tiseo M, Gelsomino F, Boggiani D et al (2011) EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations. Lung cancer 71:241\u2013243. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2010.11.014","journal-title":"Lung cancer"},{"key":"2727_CR81","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1356-9597.2004.00732.x","volume":"9","author":"S Toji","year":"2004","unstructured":"Toji S, Yabuta N, Hosomi T et al (2004) The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. Genes Cells 9:383\u2013397. \n                    https:\/\/doi.org\/10.1111\/j.1356-9597.2004.00732.x","journal-title":"Genes Cells"},{"key":"2727_CR82","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0891-5849(95)02111-6","volume":"20","author":"S Toyokuni","year":"1996","unstructured":"Toyokuni S (1996) Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20:553\u2013566. \n                    https:\/\/doi.org\/10.1016\/0891-5849(95)02111-6","journal-title":"Free Radic Biol Med"},{"key":"2727_CR83","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1158\/1078-0432.CCR-16-1971","volume":"23","author":"R Tranchant","year":"2016","unstructured":"Tranchant R, Quetel L, Tallet A et al (2016) Co-occurring mutations of tumor suppressor genes, LATS2 and NF2, in malignant pleural mesothelioma. Clin Cancer Res 23:3191\u20133202. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1971","journal-title":"Clin Cancer Res"},{"key":"2727_CR84","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1158\/2159-8290.CD-15-0063","volume":"5","author":"EM Tricker","year":"2015","unstructured":"Tricker EM, Xu C, Uddin S et al (2015) Combined EGFR\/MEK inhibition prevents the emergence of resistance in EGFR mutant lung cancer. Cancer Discov 5:960\u2013971. \n                    https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0063","journal-title":"Cancer Discov"},{"key":"2727_CR85","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ncomms2105","volume":"3","author":"Y Ueda","year":"2012","unstructured":"Ueda Y, Katagiri K, Tomiyama T et al (2012) Mst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus. Nat Commun 3:1098. \n                    https:\/\/doi.org\/10.1038\/ncomms2105","journal-title":"Nat Commun"},{"key":"2727_CR86","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s13277-013-1064-9","volume":"35","author":"L Wang","year":"2014","unstructured":"Wang L, Chen Z, Wang Y et al (2014) WWTR1 promotes cell proliferation and inhibits apoptosis through cyclin A and CTGF regulation in non-small cell lung cancer. Tumour Biol 35:463\u2013468. \n                    https:\/\/doi.org\/10.1007\/s13277-013-1064-9","journal-title":"Tumour Biol"},{"key":"2727_CR87","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ncb3113","volume":"17","author":"W Wang","year":"2015","unstructured":"Wang W, Xiao Z-D, Li X et al (2015) AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol 17:490\u2013499. \n                    https:\/\/doi.org\/10.1038\/ncb3113","journal-title":"Nat Cell Biol"},{"key":"2727_CR88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.11.019","volume":"57","author":"D Wilkinson","year":"2015","unstructured":"Wilkinson D, Jariwala J, Anderson E et al (2015) Phosphorylation of LC3 by the hippo kinases STK3\/STK4 is essential for autophagy. Mol Cell 57:55\u201368. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2014.11.019","journal-title":"Mol Cell"},{"key":"2727_CR89","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0092-8674(03)00549-X","volume":"114","author":"S Wu","year":"2003","unstructured":"Wu S, Huang J, Dong J et al (2003) hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114:445\u2013456. \n                    https:\/\/doi.org\/10.1016\/S0092-8674(03)00549-X","journal-title":"Cell"},{"key":"2727_CR90","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.1158\/0008-5472.CAN-10-1493","volume":"70","author":"C Wu","year":"2010","unstructured":"Wu C, Xu B, Yuan P et al (2010) Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients. Cancer Res 70:9721\u20139729. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1493","journal-title":"Cancer Res"},{"key":"2727_CR91","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/JTO.0b013e318248240b","volume":"7","author":"M Xie","year":"2012","unstructured":"Xie M, Zhang L, He CS et al (2012) Prognostic significance of TAZ expression in resected non-small cell lung cancer. J Thorac Oncol 7:799\u2013807. \n                    https:\/\/doi.org\/10.1097\/JTO.0b013e318248240b","journal-title":"J Thorac Oncol"},{"key":"2727_CR92","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/cgt.2013.40","volume":"20","author":"CM Xu","year":"2013","unstructured":"Xu CM, Liu WW, Liu CJ et al (2013) Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo. Cancer gene Ther 20:453\u2013460. \n                    https:\/\/doi.org\/10.1038\/cgt.2013.40","journal-title":"Cancer gene Ther"},{"key":"2727_CR93","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-3701-5-7","volume":"5","author":"W Xu","year":"2015","unstructured":"Xu W, Wei Y, Wu S et al (2015) Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib. Cell Biosci 5:7. \n                    https:\/\/doi.org\/10.1186\/2045-3701-5-7","journal-title":"Cell Biosci"},{"key":"2727_CR94","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s12094-015-1448-y","volume":"18","author":"YJ Xu","year":"2016","unstructured":"Xu YJ, Du Y, Fan Y (2016) Long noncoding RNAs in lung cancer: what we know in 2015. Clin Transl Oncol 18:660\u2013665. \n                    https:\/\/doi.org\/10.1007\/s12094-015-1448-y","journal-title":"Clin Transl Oncol"},{"key":"2727_CR95","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.4161\/cc.10.16.16873","volume":"10","author":"N Yabuta","year":"2011","unstructured":"Yabuta N, Mukai S, Okada N et al (2011) The tumor suppressor Lats2 is pivotal in aurora A and aurora B signaling during mitosis. Cell Cycle 10:2724\u20132736. \n                    https:\/\/doi.org\/10.4161\/cc.10.16.16873","journal-title":"Cell Cycle"},{"key":"2727_CR96","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.1016\/j.heliyon.2016.e00131","volume":"2","author":"N Yabuta","year":"2016","unstructured":"Yabuta N, Yoshida K, Mukai S et al (2016) Large tumor suppressors 1 and 2 regulate aurora-B through phosphorylation of INCENP to ensure completion of cytokinesis. Heliyon 2:e00131. \n                    https:\/\/doi.org\/10.1016\/j.heliyon.2016.e00131","journal-title":"Heliyon"},{"key":"2727_CR97","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ijc.29457","volume":"138","author":"B Yeung","year":"2016","unstructured":"Yeung B, Yu J, Yang X (2016) Roles of the Hippo pathway in lung development and tumorigenesis. Int J Cancer 138:533\u2013539. \n                    https:\/\/doi.org\/10.1002\/ijc.29457","journal-title":"Int J Cancer"},{"key":"2727_CR98","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2013.08.025","volume":"154","author":"F Yin","year":"2013","unstructured":"Yin F, Yu J, Zheng Y et al (2013) Spatial organization of hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin\/NF2. Cell 154:1342\u20131355. \n                    https:\/\/doi.org\/10.1016\/j.cell.2013.08.025","journal-title":"Cell"},{"key":"2727_CR99","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/carcin\/bgn200","volume":"29","author":"T Yokoyama","year":"2008","unstructured":"Yokoyama T, Osada H, Murakami H et al (2008) YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation. Carcinogenesis 29:2139\u20132146. \n                    https:\/\/doi.org\/10.1093\/carcin\/bgn200","journal-title":"Carcinogenesis"},{"key":"2727_CR100","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.18632\/oncotarget.2974","volume":"6","author":"B You","year":"2015","unstructured":"You B, Yang Y-L, Xu Z et al (2015) Inhibition of ERK1\/2 down-regulates the Hippo\/YAP signaling pathway in human NSCLC cells. Oncotarget 6:4357\u20134368. \n                    https:\/\/doi.org\/10.18632\/oncotarget.2974","journal-title":"Oncotarget"},{"key":"2727_CR101","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ng.2330","volume":"44","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Lee JC, Lin L et al (2012) Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nat Genet 44:852\u2013860. \n                    https:\/\/doi.org\/10.1038\/ng.2330","journal-title":"Nat Genet"},{"key":"2727_CR102","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/cr.2014.10","volume":"24","author":"W Zhang","year":"2014","unstructured":"Zhang W, Gao Y, Li P et al (2014) VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res 24:331\u2013343. \n                    https:\/\/doi.org\/10.1038\/cr.2014.10","journal-title":"Cell Res"},{"key":"2727_CR103","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1158\/0008-5472.CAN-14-3396","volume":"75","author":"W Zhang","year":"2015","unstructured":"Zhang W, Gao Y, Li F et al (2015) YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin. Cancer Res 75:4450. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3396","journal-title":"Cancer Res"},{"key":"2727_CR104","first-page":"4857","volume":"8","author":"L Zhang","year":"2016","unstructured":"Zhang L, Huang Y, Zhuo W et al (2016a) Fisetin, a dietary phytochemical, overcomes Erlotinib-resistance of lung adenocarcinoma cells through inhibition of MAPK and AKT pathways. Am J Transl Res 8:4857\u20134868","journal-title":"Am J Transl Res"},{"key":"2727_CR105","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12935-016-0366-6","volume":"16","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, He R-Q, Dang Y-W et al (2016b) Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells. Cancer Cell Int 16:89. \n                    https:\/\/doi.org\/10.1186\/s12935-016-0366-6","journal-title":"Cancer Cell Int"},{"key":"2727_CR106","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/onc.2010.606","volume":"30","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Hao Y, Liu N et al (2011) TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30:2181\u20132186. \n                    https:\/\/doi.org\/10.1038\/onc.2010.606","journal-title":"Oncogene"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-018-2727-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2727-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2727-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T19:10:45Z","timestamp":1564773045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-018-2727-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":106,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2727"],"URL":"https:\/\/doi.org\/10.1007\/s00432-018-2727-0","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"10 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"These authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}